| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $117.3M | +28.4% |
| Cost of Revenue | $49.1M | +36.9% |
| Gross Profit | $68.2M | +23.0% |
| R&D Expense | $2.4M | +78.5% |
| SG&A Expense | $28.7M | +11.0% |
| Operating Income | -$12.1M | -18.9% |
| Interest Expense | $4.2M | +41.6% |
| Pre-tax Income | -$16.3M | -1468.2% |
| Income Tax | $187K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.2M | +8.5% |
| Accounts Receivable | $20.7M | -0.3% |
| Inventory | $38.6M | +4.7% |
| Current Assets | $67.1M | +3.5% |
| Total Assets | $93.8M | +1.3% |
| Current Liabilities | $28.6M | +24.3% |
| Long-term Debt | $22.0M | +28.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.9M | -25.0% |
| Capital Expenditures | $4.1M | +182.5% |
| Investing Cash Flow | -$3.7M | +84.9% |
| Financing Cash Flow | $16.1M | -18.4% |
| Free Cash Flow | -$16.0M | -45.9% |
| +111.0% |
| Net Income | -$16.4M | -2592.3% |
| EPS (Basic) | -$0.12 | -1300.0% |
| EPS (Diluted) | -$0.12 | -1300.0% |
| Total Liabilities |
| $50.9M |
| +23.3% |
| Stockholders' Equity | $43.0M | -16.3% |